Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures tepid as Middle East tensions keep investors wary
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- Snowflake soars 20% on earnings beat and raised guidance
Sucampo Pharma (SCMP) Tops Q4 EPS by 20c, Names CFO
March 8, 2017 6:41 AM ESTSucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.68, $0.20 better than the analyst estimate of $0.48. Revenue for the quarter came in at $73 million versus the consensus estimate of $66 million.
Sucampo today reiterated its guidance for the full year ending December 31, 2017.
Additionally, today Sucampo... More
